Artigo Revisado por pares

Ensuring safety of the 2011 trivalent influenza vaccine in young children

2011; Wiley; Volume: 195; Issue: 1 Linguagem: Inglês

10.5694/j.1326-5377.2011.tb03194.x

ISSN

1326-5377

Autores

Christopher C. Blyth, Tracy Y Markus, Paul V. Effler, Peter Richmond,

Tópico(s)

Vaccine Coverage and Hesitancy

Resumo

Medical Journal of AustraliaVolume 195, Issue 1 p. 52-52 Letter Ensuring safety of the 2011 trivalent influenza vaccine in young children Christopher C Blyth, Corresponding Author Christopher C Blyth Associate Professor; Associate Professor; Associate Professor ccblyth@meddent.uwa.edu.au School of Paediatrics and Child Health, University of Western Australia, Perth, WA. Department of Paediatric and Adolescent Medicine, Princess Margaret Hospital, Perth, WA. Vaccine Trials Group, Telethon Institute for Child Health Research, Perth, WA.Correspondence: ccblyth@meddent.uwa.edu.auSearch for more papers by this authorTracy Y Markus, Tracy Y Markus Paediatric Registrar Vaccine Trials Group, Telethon Institute for Child Health Research, Perth, WA.Search for more papers by this authorPaul V Effler, Paul V Effler Medical Coordinator Prevention and Control Program, Communicable Disease Control Directorate, WA Health, Perth, WA.Search for more papers by this authorPeter C Richmond, Peter C Richmond Associate Professor; Associate Professor; Associate Professor School of Paediatrics and Child Health, University of Western Australia, Perth, WA. Department of Paediatric and Adolescent Medicine, Princess Margaret Hospital, Perth, WA. Vaccine Trials Group, Telethon Institute for Child Health Research, Perth, WA.Search for more papers by this author Christopher C Blyth, Corresponding Author Christopher C Blyth Associate Professor; Associate Professor; Associate Professor ccblyth@meddent.uwa.edu.au School of Paediatrics and Child Health, University of Western Australia, Perth, WA. Department of Paediatric and Adolescent Medicine, Princess Margaret Hospital, Perth, WA. Vaccine Trials Group, Telethon Institute for Child Health Research, Perth, WA.Correspondence: ccblyth@meddent.uwa.edu.auSearch for more papers by this authorTracy Y Markus, Tracy Y Markus Paediatric Registrar Vaccine Trials Group, Telethon Institute for Child Health Research, Perth, WA.Search for more papers by this authorPaul V Effler, Paul V Effler Medical Coordinator Prevention and Control Program, Communicable Disease Control Directorate, WA Health, Perth, WA.Search for more papers by this authorPeter C Richmond, Peter C Richmond Associate Professor; Associate Professor; Associate Professor School of Paediatrics and Child Health, University of Western Australia, Perth, WA. Department of Paediatric and Adolescent Medicine, Princess Margaret Hospital, Perth, WA. Vaccine Trials Group, Telethon Institute for Child Health Research, Perth, WA.Search for more papers by this author First published: 04 July 2011 https://doi.org/10.5694/j.1326-5377.2011.tb03194.xCitations: 7Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article.Citing Literature Volume195, Issue1July 2011Pages 52-52 RelatedInformation

Referência(s)
Altmetric
PlumX